What are the targets of diterpenes in bacteria?
Best insight from top research papers
Diterpenes have been found to target bacteria by exhibiting antibacterial activity against various strains. ent-Copalic acid (CA) showed promising activity against Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus agalactiae, and Streptococcus dysgalactiae . The semisynthetic compound 7-acetoxy-mulin-9,12-diene exhibited antibacterial activity against Staphylococcus aureus . ent-pimara-8(14),15-dien-19-oic acid and its sodium salt, as well as ent-8(14),15-pimaradien-3β-ol, displayed antimicrobial activity against various microorganisms responsible for dental root canal infections . ent-pimara-8(14),15-dien-19-oic acid was found to have bactericidal kinetics and antibiofilm efficacy against oral pathogens, including Streptococcus mutans . Overall, diterpenes have shown potential as antibacterial agents against a range of bacteria, including those associated with bovine mastitis, dental root canal infections, and oral pathogens.
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
49 Citations | The paper does not provide information about the specific targets of diterpenes in bacteria. The paper focuses on the antimicrobial activity of diterpenes from Viguiera arenaria against endodontic bacteria. |
| The provided paper does not mention the targets of diterpenes in bacteria. | |
4 Citations | The paper does not provide information about the specific targets of the diterpenes in bacteria. |
| The paper does not provide information about the targets of diterpenes in bacteria. | |
| The provided paper does not mention the specific targets of diterpenes in bacteria. |
Related Questions
What recent advances have been made in identifying new targets for combating bacterial resistance?5 answersRecent advances have been made in identifying new targets for combating bacterial resistance. Methods for finding drug targets from omics databases have been developed, including phage-driven and bacterial cytological profiling approaches. Additionally, computational tools, machine learning algorithms, and databases have been established for antibacterial target identification. Furthermore, nanomaterials have been explored as alternative approaches for antibacterial treatment, with targeted bacteria depletion being a promising strategy. These nanomaterials can passively target bacteria by serving as alternatives to antibiotics, or actively target bacteria through biomimetic or biomolecular surface features. The development of antimicrobial materials and drug delivery systems has also contributed to combating drug-resistant bacteria. Overall, these advancements in target identification and treatment strategies provide new opportunities for addressing bacterial resistance.
What are some methods for validating targets of small RNA in bacteria?4 answersMethods for validating targets of small RNA in bacteria include predictive computational searches, experimental approaches such as microarrays, next-generation sequencing, and co-immunoprecipitation with Hfq. Another method involves the co-purification of target mRNAs bound to MS2-tagged sRNAs expressed in vivo, followed by RNAseq analysis to determine the identity of RNA interacting partners. This method has been successfully applied to most sRNAs of E. coli and Salmonella. Additionally, a method using RNA-binding small molecules conjugated with bleomycin A5 has been developed to selectively cleave oncogenic non-coding RNAs, leading to reversal of phenotype. These methods provide valuable tools for identifying and validating targets of small RNA in bacteria, contributing to our understanding of gene expression regulation and potential therapeutic interventions.
What are the targets of diterpenes in MRSA bacteria ?5 answersDiterpenes have been found to target MRSA bacteria. Sincoetsin C, a diterpene isolated from Coleus blumei, displayed the most activity against MRSA with a minimum inhibitory concentration of 128 μg/mL. Phenolic diterpenes, including ferruginol and taxodione, showed potent activity against MRSA with MIC values ranging from 4-10 μg/mL. Ent-kaurenoic acid and ent-pimaradienoic acid, as well as their derivatives, were classified as promising bactericidal antimicrobial agents against MDR bacteria, including MRSA. Ent-8(14),15-pimaradien-3β-ol, a pimarane-type diterpene, exhibited promising minimal inhibitory concentration values against nosocomial multidrug-resistant bacteria, including MRSA. Mulinane and azorellane diterpenes, along with their semisynthetic derivatives, showed antibacterial activity against reference and multidrug-resistant strains of MRSA.
What are the phytochemicals responsible for antibacterial activity of a plant?3 answersPhytochemicals responsible for the antibacterial activity of plants include flavonoids, polyphenols, alkaloids, terpenes, cannabinoids, xanthones, and fatty acids. These compounds have been found to exhibit antimicrobial effects against various bacteria, including Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, and Bacillus sp.. The antibacterial activity of phytochemicals is attributed to their ability to destroy the membrane structure of bacteria and inhibit efflux pumps. Some phytochemicals have also shown synergistic effects when combined with antibiotics, enhancing their antibacterial activity. Examples of phytochemicals with significant antibacterial activity include rubraxanthone, parvixanthone G, cowanin, garcihombronane B, and garcihombronane C. Further research is needed to explore the potential of these phytochemicals as natural food preservatives and to prevent the emergence of bacterial resistance.
What is the production of target secondary metabolites in tobacco?5 answersTobacco plants have the ability to produce a wide range of secondary metabolites. Increased levels of aromatic amino acids (AAAs) in tobacco plants have been shown to lead to higher levels of phenylalanine, tyrosine, and tryptophan, which are precursors for secondary metabolites. Metabolic profiling analysis revealed that the leaves of transgenic tobacco plants with increased AAAs had increased levels of phenylpropanoids, which are secondary metabolites derived from phenylalanine. Ergosterol, a steroid from fungal membranes, has been found to trigger the biosynthesis of sesquiterpenoids, a class of secondary metabolites, in tobacco cells. The production of secondary metabolites in tobacco can be influenced by metabolic engineering, which involves manipulating the expression of genes involved in secondary metabolism. Overall, tobacco plants have the potential to produce a variety of secondary metabolites, and their production can be modulated through genetic manipulation and exposure to specific stimuli.
How can targeted proteomics be used to study pathogenic bacteria?5 answersTargeted proteomics, specifically quantitative proteomics using selected or parallel reaction monitoring, has been used to study pathogenic bacteria. This approach has been instrumental in mapping bacterial proteomes, leading to a better understanding of the molecular mechanisms underlying bacterial infection and bacteria-host interactions. Targeted proteomics has been applied for bacteria identification, biomarker discovery, and characterization of bacterial virulence and antimicrobial resistance. It has also been used to investigate the response of bacteria to antibiotics, providing insights into bacterial adaptation, antibiotic resistance, and tolerance development. Additionally, targeted proteomics has been used to study host-pathogen interactions, revealing information about the proteomes of both the host and the pathogen and elucidating the mechanisms dictating these interactions. Overall, targeted proteomics offers a sensitive and specific quantitative approach to study pathogenic bacteria, contributing to the fight against infectious diseases.